Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

to file treatment protocols, which would allow physicians to use their drugs ahead of approval. The situation could also boost sales of Allschwil-based Actelion's Zavesca (miglustat).

Based in Allschwil, Alentis specialises in antibody-drug conjugates (ADCs) and antibodies targeting CLDN1 for oncology and multi-organ fibrosis treatments. The company's lead ADC candidate ...

Basilea Pharmaceutica Ltd announced that its antifungal drug, Cresemba® (isavuconazole), surpassed sales targets in Japan, triggering a CHF 1.2 ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

With 37 new spin-offs, ETH Zurich continues its long-term upward trend in the launch of new companies from its research.

SKAN Group AG announces preliminary key figures for the 2024 financial year revealing increased net sales and EBITDA. Detailed financial results will be released on March 25, 2025 ...

Drawing on a fascinating enabling technology of photo alignment, Rolic continually develops novel applications for use in manufacturing of LCDs, OLEDs, OVPs and innovative security elements.